Digital Health: Page 25


  • Deep Dive

    CGM, insulin pump players look to 2021 as watershed year for diabetes wearables market

    Insulet, Dexcom and Medtronic have product launches set for this year, and all look to capitalize on the recent skyrocketing of virtual care due to the coronavirus pandemic.

    By Jan. 29, 2021
  • iRhythm Zio XT
    Image attribution tooltip
    Permission granted by iRhythm Technologies
    Image attribution tooltip
    Q&A

    New iRhythm CEO on national pricing setback, Medtronic market expansion lessons

    Michael Coyle will try to build off the cardiac monitoring company's recent success amid a telehealth boom. Shares have jumped by over 175% in the last 12 months.

    By Jan. 28, 2021
  • England's NHS moves to boost access to Quidel, Roche, other medtech products

    To be a part of the National Health Services' MedTech Funding Mandate, companies must be able to make the claim that their products generate net savings in their first year of use.

    By Jan. 27, 2021
  • Philips beats Q4 expectations as COVID-19 boosts connected care, slows procedures

    The Dutch conglomerate will continue to be active on the M&A front, CEO Frans van Houten told investors, after striking two deals in the space over the past month worth more than $3.4 billion.

    By Jan. 25, 2021
  • Healthcare funding shatters records in 2020, helped by COVID-19

    Medical device startups raised roughly $6 billion in the fourth quarter, a high point over the last three years, according to a CB Insights report.

    By Rebecca Pifer Parduhn • Jan. 22, 2021
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    Hillrom makes cardiac monitoring play with $375M BardyDx buy

    The deal fits Hillrom's existing heart portfolio and efforts to connect devices to the internet, analysts said, but one raised concerns about Medicare reimbursement.

    By Jan. 20, 2021
  • Forging trust in AI, sustaining the virtual care boom and other CES takeaways

    "You can't just set a piece of software in front of somebody and say 'trust me,'" Christina Silcox, digital health fellow at the Duke-Margolis Center for Health Policy, said at the consumer tech conference.

    By Rebecca Pifer Parduhn • Jan. 19, 2021
  • MedTech Europe calls for EU to retain support for digital health post-pandemic

    The industry wants reimbursement changes and other measures to make digital health permanent.

    By Jan. 19, 2021
  • Philips to acquire Capsule Technologies in $635M deal, growing patient data capabilities

    The move follows the medtech giant's $2.8 billion acquisition of cardiac monitoring company BioTelemetry in December, one of 2020's largest deals.

    By Jan. 19, 2021
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Neuromod portfolios advance at Medtronic, Boston Scientific, Abbott

    The flurry of activity is further evidence of the medtech industry’s latest attempts to make progress in a sector criticized as stagnant just one year ago.

    By Jan. 15, 2021
  • Google calls Fitbit acquisition complete despite ongoing DOJ review

    The search giant closed the deal because the department's 14-month investigation period expired without any objection. However, DOJ could still sue to unwind the buy.

    By Rebecca Pifer Parduhn • Jan. 14, 2021
  • telehealth header for 6 months in package
    Image attribution tooltip
    Brian Tucker/MedTech Dive
    Image attribution tooltip

    Remote monitoring, wearable companies look to capitalize on virtual care boom: JPM21

    Diabetes players Dexcom and Insulet both projected business growth and market expansion for this year during presentations.

    By Jan. 14, 2021
  • CMS breakthrough rule called tailwind for Abbott, J&J and Medtronic

    The policy gives developers of FDA-designated breakthrough products coverage for Medicare's 60 million beneficiaries on the day of approval.

    By Jan. 13, 2021
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Medtech M&A to take off after pandemic slowed deals in 2020: EY

    Dealmaking in 2021 will be fueled by financial firepower across the industry at an "all-time high" of nearly $500 billion, according to the consultants.

    By Jan. 10, 2021
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Color raises $167M to scale up US testing and telehealth services

    The health technology company, with a valuation of $1.5 billion, intends to use the money to help build a national tech-based public health infrastructure capable of providing healthcare services to large populations.

    By Jan. 5, 2021
  • Philips clinical-grade wearable study in early COVID-19 detection gets DoD funds

    The project will assess the FDA-cleared BioSticker, coming a week after the Dutch medtech giant doubled down on remote patient monitoring by scooping up BioTelemetry for $2.8 billion.

    By Dec. 23, 2020
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    Medtronic, GE, Philips embrace AI amid regulatory limbo around algorithms

    The focus comes as FDA action seems stalled. It's been a year and a half since the agency issued a discussion paper on its proposed regulatory framework for machine learning-based software as a medical device.  

    By Dec. 21, 2020
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Medtech's COVID-19 recovery will have to wait for second half of 2021: analysts

    Wall Street expects declines in elective care to continue as coronavirus cases keep rising. However, a more widespread rollout of vaccines could spur momentum later in the year.

    By Dec. 21, 2020
  • Philips buys cardiac monitoring company BioTelemetry in $2.8B deal

    The Dutch conglomerate said that the move will expand its remote patient monitoring business beyond the hospital space. Baird called the pact a surprise but the valuation fair.

    By Dec. 18, 2020
  • Image attribution tooltip
    Danielle Ternes
    Image attribution tooltip

    CDRH headed for 'reset' in 2021 after COVID-19 derailed priorities, Shuren says

    After a "massive increase" in work due to the pandemic, the device center anticipates continuing to manage coronavirus projects while also focusing on MDUFA V and new programs.

    By Dec. 3, 2020
  • United States $100 bills
    Image attribution tooltip
    "Money" by Ervins Strauhmanis is licensed under CC BY 2.0
    Image attribution tooltip

    Everlywell raises $175M to expand at-home health testing, virtual care services

    The startup was first to win FDA emergency approval for a COVID-19 test self-collection kit. Sales of most tests are growing more than 100% year over year, driven by deals with Target, Walgreens and CVS, though competition is rising.

    By Dec. 3, 2020
  • iRhythm goes back to drawing board as CMS reverses national pricing move

    In a departure from an August proposal, the agency will leave it up to local contractors to determine pricing for new permanent codes reimbursing the EKG patches service. Shares fell 24% after the news late Tuesday.

    By Maria Rachal • Dec. 2, 2020
  • Medtechs, working with FDA, offer guidance for remote control of medical devices during pandemic

    GE Healthcare, Medtronic, Philips and ResMed are among those that have modified products with such capabilities to create safe physical distance between providers and COVID-19 patients.

    By Dec. 2, 2020
  • Digital therapeutic De Novos climb with FDA nod to IBS treatment

    Despite a series of first-of-their-kind authorizations for such tech, total 2020 De Novo OKs currently match a 2019 low in recent years.

    By Maria Rachal • Dec. 1, 2020
  • iRhythm Zio XT
    Image attribution tooltip
    Permission granted by iRhythm Technologies
    Image attribution tooltip

    iRhythm gains UK support for EKG system while awaiting key final rule from CMS

    The ambulatory cardiac monitoring system is one of just six medtech products recommended this year in guidance from the U.K. National Institute for Health and Care Excellence. The focus is on individuals with suspected arrhythmias.

    By Maria Rachal • Dec. 1, 2020